| | | Copy number gain | See cases | |
| | LOC126862582, LOC126862583 +1753 more | Copy number gain | See cases | |
| | C17orf47, CCDC182 +168 more | Copy number loss | See cases | |
| | LOC129390903, LOC130061310 +2 more | Duplication | Fanconi anemia complementation group O | |
| | LOC129390903, LOC130061310 +2 more | Deletion | Fanconi anemia complementation group O | |
| | LOC129390903, LOC130061310 +2 more | Duplication | Fanconi anemia complementation group O | |
| | | Deletion | Fanconi anemia complementation group O | |
| | LOC130061310, LOC129390903 +2 more | Duplication | Fanconi anemia complementation group O | |
| | LOC129390903, LOC130061310 +2 more | Deletion | Fanconi anemia complementation group O | |
| | | Duplication | Fanconi anemia complementation group O | |
| | LOC129390903, LOC130061310 +2 more | Deletion | Fanconi anemia complementation group O | |
| | | Insertion (splice donor variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Duplication (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (splice donor variant) | Fanconi anemia complementation group O +2 more | GPathogenic/Likely pathogenic |
| | | Indel (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome | |
| | | Indel (intron variant) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome | |
| | | Deletion (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | not specified +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O | |